Metraipolis › archive › dc_3c8fecc527f7

Highly Active Antiretroviral Therapy (HAART) - "Sulfonyl", and anal cancer outcomes from patients living with HIV: a retrospective cohort — Europe PMC PMID:40842031

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40842031
DOI
10.1186/s13027-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-10T11:35:43.213Z
SHA-256 of the archived text
1c2c9d6739a995cf5eb75a232966008f6b93718dc5dba851da10252aa2b6bfca
Stable URL of this page
https://metraipolis.com/documento/dc_3c8fecc527f7

How to cite

Highly Active Antiretroviral Therapy (HAART) - "Sulfonyl", and anal cancer outcomes from patients living with HIV: a retrospective cohort — Europe PMC PMID:40842031 — Europe PMC (en), https://europepmc.org/article/MED/40842031 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3c8fecc527f7 (Metraipolis archive dc_3c8fecc527f7, sha256 1c2c9d6739a995cf5eb75a232966008f6b93718dc5dba851da10252aa2b6bfca)
BibTeX
@misc{dc3c8fecc527f7,
  title = {Highly Active Antiretroviral Therapy (HAART) - "Sulfonyl", and anal cancer outcomes from patients living with HIV: a retrospective cohort — Europe PMC PMID:40842031},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40842031},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3c8fecc527f7; sha256 1c2c9d6739a995cf5eb75a232966008f6b93718dc5dba851da10252aa2b6bfca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40842031. Agents can read the archived copy with the MCP tool read_document.